Loading…
Passage Bio, Inc. is projected to decline to $5.45 by 2027, a -1% move from its current price of $5.52. PASG is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $5.25 | $5.53 | $5.81 | +0.09% |
| May 30 | $5.15 | $5.53 | $5.94 | +0.18% |
| May 31 | $5.07 | $5.54 | $6.05 | +0.28% |
| Jun 1 | $5.00 | $5.54 | $6.13 | +0.37% |
| Jun 2 | $4.95 | $5.55 | $6.21 | +0.46% |
| Jun 3 | $4.90 | $5.55 | $6.29 | +0.55% |
| Jun 4 | $4.86 | $5.56 | $6.36 | +0.64% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.86 | $5.56 | $6.36 | +0.64% |
| Week 2 | $4.62 | $5.59 | $6.76 | +1.29% |
| Week 3 | $4.46 | $5.63 | $7.10 | +1.94% |
| Week 4 | $4.33 | $5.66 | $7.41 | +2.60% |
| Week 5 | $4.22 | $5.70 | $7.70 | +3.26% |
| Week 6 | $4.13 | $5.74 | $7.98 | +3.92% |
| Week 7 | $4.04 | $5.77 | $8.24 | +4.59% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Passage Bio, Inc. is a genetic medicines company that develops gene therapies for central nervous system diseases.
It develops PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; and PBKR03, for the treatment of Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other programs for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc.
Passage Bio, Inc. was incorporated in 2017 and is based in Philadelphia, Pennsylvania.
Passage Bio (PASG) current price is $5.23 with a market cap of $16.76M and a rank of 5004.
Forecasts show a year-by-year path with a 2026 average of $5.23 and a 2026 min/max of $4.08/$6.22, respectively, with ROI 0 and sentiment NEUTRAL.
Longer-horizon outlooks imply higher averages: 2030 avg $7.26 with ROI 39 and sentiment BULLISH; 2040 avg $9.42 with ROI 80.3 and sentiment BULLISH; 2050 avg $15.32 with ROI 193.3 and sentiment BULLISH.
A major floor 26.1% below — a decisive break under it would weaken the trend.
The nearest floor, 26.1% below — buyers have tended to step in here.
The nearest ceiling, 115.4% above — a clean break opens room to run.
A major ceiling 171.3% above — clearing it would confirm fresh momentum.
Key PASG support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PASG market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.33 | Buy | $5.37 | Buy |
| MA 10 | $5.30 | Buy | $5.27 | Buy |
| MA 20 | $4.95 | Buy | $5.46 | Buy |
| MA 50 | $6.77 | Sell | $6.56 | Sell |
| MA 100 | $8.92 | Sell | $7.62 | Sell |
| MA 200 | $8.52 | Sell | $8.42 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.20 | Neutral |
| Stoch RSI (14) | 98.03 | Sell |
| CCI (20) | 92.85 | Neutral |
| Williams %R (14) | -2.04 | Info |
| MACD (12,26,9) | 0.21 | Buy |
| ROC (12) | 31.12 | Buy |
| Bollinger %B (20,2) | 0.80 | Neutral |
| Stochastic %K (14) | 97.96 | Sell |
| TRIX (15) | -1.52 | Sell |
| Awesome (5,34) | -1.11 | Sell |
| Ultimate (7,14,28) | 65.59 | Neutral |
| Momentum (10) | 0.49 | Buy |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 5.45 | Buy |
| ADX (14) | 20.73 | Sell |
| ATR (14) | 0.28 | Info |
The 30-day technical picture is NEUTRAL with RSI14 at 40.
SMA50 is $6.85 and SMA200 is $8.52, with a support level at $4.08 and a resistance at $11.89.
The 30-day range spans from $3.70 to $7.38, and annualized volatility is 100.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.08 | $5.52 | $6.58 | 0% | Neutral | |
| $3.96 | $5.45 | $8.11 | -1% | Neutral | |
| $4.20 | $6.11 | $9.64 | +11% | Neutral | |
| $4.99 | $7.61 | $12.58 | +38% | Bullish | |
| $4.85 | $7.74 | $13.27 | +40% | Bullish | |
| $4.09 | $6.80 | $12.06 | +23% | Bullish | |
| $4.05 | $7.01 | $12.79 | +27% | Bullish | |
| $3.69 | $6.62 | $12.42 | +20% | Bullish | |
| $3.88 | $7.23 | $13.88 | +31% | Bullish | |
| $4.96 | $9.56 | $18.76 | +73% | Bullish | |
| $4.73 | $10.51 | $22.59 | +90% | Bullish | |
| $7.54 | $16.76 | $38.55 | +204% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $4.08 | $5.52 | $6.59 | +0.00% |
| June 2026 | $5.00 | $5.98 | $7.41 | +8.35% |
| July 2026 | $4.93 | $6.00 | $7.62 | +0.32% |
| August 2026 | $4.60 | $5.67 | $7.33 | -5.54% |
| September 2026 | $4.58 | $5.70 | $7.48 | +0.58% |
| October 2026 | $4.56 | $5.73 | $7.62 | +0.51% |
| November 2026 | $4.13 | $5.23 | $7.04 | -8.69% |
| December 2026 | $3.79 | $4.84 | $6.58 | -7.47% |
Click any year to see its month-by-month PASG forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect PASG to range from $4.08 to $6.58 through 2026. The $5.52 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The PASG price prediction for 2027 points to an average of $5.45 (low $3.96, high $8.11) — a potential decline of -1% on today's $5.52. A consolidation phase looks the most probable path here.
In 2028, PASG is projected to trade between $4.20 and $9.64, averaging $6.11 — a potential gain of +11% from today's $5.52. That is up +12% on the projected 2027 average. Price action looks broadly range-bound.
Passage Bio, Inc.'s 2029 outlook centres on $7.61, within a $4.99 to $12.58 range. That is up +25% on the projected 2028 average. That marks a +38% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, PASG could reach as high as $13.27, with a base case around $7.74 and support toward $4.85 — roughly +40% from $5.52. Momentum favours further upside here.
Expect PASG to range from $4.09 to $12.06 through 2031. The $6.80 average target implies a +23% move from current prices. That is -12% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
The PASG price prediction for 2032 points to an average of $7.01 (low $4.05, high $12.79) — a potential gain of +27% on today's $5.52. Momentum favours further upside here.
In 2033, PASG is projected to trade between $3.69 and $12.42, averaging $6.62 — a potential gain of +20% from today's $5.52. That is -5% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
Passage Bio, Inc.'s 2034 outlook centres on $7.23, within a $3.88 to $13.88 range. That is up +9% on the projected 2033 average. That marks a +31% change versus current levels. Momentum favours further upside here.
By 2035, PASG could reach as high as $18.76, with a base case around $9.56 and support toward $4.96 — roughly +73% from $5.52. Buyers look set to stay in control over this stretch.
Expect PASG to range from $4.73 to $22.59 through 2040. The $10.51 average target implies a +90% move from current prices. That is up +10% on the projected 2035 average. Momentum favours further upside here.
The PASG price prediction for 2050 points to an average of $16.76 (low $7.54, high $38.55) — a potential gain of +204% on today's $5.52. Buyers look set to stay in control over this stretch.
Investing $1,000 in PASG today (≈ 181.15942 PASG) could be worth
$3,036.45
+$2,036.45 (+204%) by 2050 · US Dollar
Based on the average projected PASG price of $16.76 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PASGwould be worth at today's price.
$1,000 invested in PASG on May 27, 2025 (≈ 139.664807 PASG) would be worth
$770.95
-$229.05 (-22.9%) today · 0.77× · US Dollar
Based on a PASG entry price of $7.16 vs. today's $5.52.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.2 | $1,061.54 | +6.2% |
| 1 month ago | $5.71 | $966.73 | -3.3% |
| 3 months ago | $8.66 | $637.41 | -36.3% |
| 6 months ago | $8.83 | $625.14 | -37.5% |
| 1 year ago | $7.16 | $770.95 | -22.9% |
| All time (5.0y) ago | $260.8 | $21.17 | -97.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PASG forecast.
Our base-case forecast reaches $11.00 around 2050.
Implied market cap at $11.00: $35.29M
Looking ahead, the multi-year forecast shows notable upside potential despite varying sentiment across years.
For 2030, the avg price is $7.26 with ROI 39 and sentiment BULLISH.
For 2040, the avg price is $9.42 with ROI 80.3 and sentiment BULLISH.
For 2050, the avg price is $15.32 with ROI 193.3 and sentiment BULLISH.
These figures illustrate a path toward higher prices over time, but they are estimates, not guarantees, and involve uncertainty. The forecast also lists a 2050 max of $35.24, underscoring the potential for substantial upside in favorable scenarios.
Tap a question to reveal the answer.
The forecast for 2030 shows avg $7.26, min $4.49, max $12.59, ROI 39, sentiment BULLISH.
In 2026 the forecast shows avg $5.23 with ROI 0 and NEUTRAL sentiment. Longer horizons show higher ROIs (2030 ROI 39, 2040 ROI 80.3, 2050 ROI 193.3) and bullish sentiment, but these are estimates, not guarantees.
The forecast lists a 2050 max of $35.24, which indicates a path that includes values above $20 in the high case.
Sentiment NEUTRAL; RSI14 is 40. SMA50 is $6.85; SMA200 is $8.52. Support is $4.08 and resistance is $11.89. The 30-day range is $3.70 to $7.38; annualized volatility is 100.
Current price is $5.23 and market cap is $16.76M. The asset rank is 5004.
Passage Bio, Inc. Community Discussion
0Share your Passage Bio, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.